INFECTIOUS DISEASE SOCIETY OF AMERICA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2005–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	6	1
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HART HEALTH STRATEGIES	—	84

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	83
SENATE	83
Health & Human Services, Dept of (HHS)	33

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	84

INFECTIOUS DISEASE SOCIETY OF AMERICA — Lobbying Disclosure | Poliscope